tradingkey.logo
tradingkey.logo
Search

Biontech SE

BNTX
Add to Watchlist
96.730USD
+0.330+0.34%
Close 09-11 16:00ET
24.32BMarket Cap
LossP/E TTM

BNTX Financials

See Biontech SE's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
24.32B
Dividend TTM
0.00
P/E TTM
-22.05
EPS TTM
-4.39
Revenue
3.33B
Net Profit
-665.30M
ROE
-6.66%
ROA
-5.93%

Biontech SE Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
-3.70/-2.42
Revenue / Forecast
121.75M/182.32M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-96.23%-3.70
-29.64%-2.43
-229.57%-1.47
-115.42%-0.14
47.61%-1.89
-32.35%-1.87
-46.36%1.13
28.92%0.91
-397.11%-3.60
-174.03%-1.41
-75.73%2.11
--0.71
---0.72
--1.91
--8.70
--29.47
----
----
----
----
Revenue
-59.65%121.75M
-33.24%138.08M
-28.86%781.57M
15.23%1.32B
91.82%225.41M
-7.26%161.57M
-18.90%1.10B
36.97%1.14B
-22.91%117.51M
-84.99%174.22M
-65.82%1.35B
-75.81%835.56M
-95.14%152.43M
-80.78%1.16B
-20.09%3.96B
-34.22%3.45B
-30.68%3.14B
257.61%6.04B
1581.68%4.96B
9089.66%5.25B
Net Profit
-111.56%-946.30M
-32.20%-621.90M
-209.66%-262.70M
-113.68%-24.92M
54.70%-334.14M
-25.59%-367.51M
-42.88%239.57M
21.51%182.13M
-326.20%-737.58M
-164.12%-292.63M
-80.13%419.40M
-91.59%149.88M
-110.55%-173.06M
-86.98%456.38M
-25.63%2.11B
-35.69%1.78B
-30.94%1.64B
276.77%3.50B
806.09%2.84B
1656.91%2.77B
Net Margin
-424.35%-777.27%
-98.00%-450.38%
-254.14%-33.61%
-111.87%-1.89%
76.38%-148.24%
-35.42%-227.46%
-29.57%21.81%
-11.28%15.91%
-452.83%-627.66%
-527.10%-167.96%
-41.87%30.96%
--17.94%
---113.54%
--39.33%
--53.26%
--54.91%
----
----
----
----
Gross Margin
-89.93%8.14%
-45.88%40.47%
-10.57%72.82%
2.47%91.01%
7.90%80.90%
-14.72%74.78%
-7.35%81.43%
8.41%88.82%
2519.64%74.98%
-5.19%87.69%
-8.17%87.89%
--81.93%
--2.86%
--92.48%
--95.71%
--78.43%
----
----
----
----
Debt to assets ratio
24.71%1.55%
3.88%1.44%
7.78%1.22%
5.70%1.15%
8.83%1.25%
30.28%1.38%
18.47%1.13%
19.66%1.09%
23.70%1.14%
11.73%1.06%
4.48%0.95%
--0.91%
--0.93%
--0.95%
--0.91%
--1.21%
----
----
----
----
Revenue
-59.65%121.75M
-33.24%138.08M
-28.86%781.57M
15.23%1.32B
91.82%225.41M
-7.26%161.57M
-18.90%1.10B
36.97%1.14B
-22.91%117.51M
-84.99%174.22M
-65.82%1.35B
-75.81%835.56M
-95.14%152.43M
-80.78%1.16B
-20.09%3.96B
-34.22%3.45B
-30.68%3.14B
257.61%6.04B
1581.68%4.96B
9089.66%5.25B
Operating profit
-101.98%-1.10B
-36.26%-788.86M
-171.28%-120.16M
-154.97%-20.32M
50.98%-406.48M
-2.85%-452.27M
-67.51%168.57M
-51.65%36.96M
-80.75%-829.16M
-166.38%-439.73M
-83.80%518.78M
-96.55%76.43M
-124.33%-458.73M
-85.11%662.49M
-21.05%3.20B
-43.37%2.22B
-46.85%1.89B
247.28%4.45B
1846.32%4.06B
2579.09%3.91B
Net Profit
-111.56%-946.30M
-32.20%-621.90M
-209.66%-262.70M
-113.68%-24.92M
54.70%-334.14M
-25.59%-367.51M
-42.88%239.57M
21.51%182.13M
-326.20%-737.58M
-164.12%-292.63M
-80.13%419.40M
-91.59%149.88M
-110.55%-173.06M
-86.98%456.38M
-25.63%2.11B
-35.69%1.78B
-30.94%1.64B
276.77%3.50B
806.09%2.84B
1656.91%2.77B
Current assets
-4.31%17.64B
2.72%18.16B
-19.88%13.91B
-19.13%13.74B
-17.52%13.77B
-18.62%13.81B
-2.94%17.36B
-2.87%17.00B
-4.42%16.69B
-7.03%16.97B
-11.92%17.89B
-17.57%17.50B
-11.89%17.46B
-1.03%18.25B
50.30%20.31B
81.57%21.23B
175.66%19.82B
532.61%18.44B
849.44%13.51B
1163.96%11.69B
Total current liabilities
4.94%2.25B
18.86%2.06B
-20.79%1.85B
-16.80%1.93B
-27.78%1.60B
-9.06%1.36B
22.83%2.33B
37.50%2.32B
33.97%2.22B
5.82%1.49B
-30.61%1.90B
-57.30%1.69B
-57.04%1.65B
-61.41%1.41B
-12.43%2.73B
-6.61%3.95B
42.80%3.85B
237.83%3.65B
503.24%3.12B
1759.61%4.23B
Total assets
-6.32%23.45B
2.81%24.64B
-8.94%18.94B
-10.03%18.53B
-7.90%18.70B
-9.42%18.72B
-1.29%20.80B
-0.63%20.60B
0.51%20.30B
3.01%20.67B
-2.28%21.07B
-8.37%20.73B
-2.65%20.20B
4.33%20.06B
51.95%21.56B
84.20%22.62B
166.21%20.75B
454.78%19.23B
616.92%14.19B
900.11%12.28B
Total liabilities
-17.77%2.98B
8.86%2.78B
-17.30%2.38B
-17.72%2.49B
-6.33%2.71B
-6.19%1.99B
13.87%2.88B
38.34%3.02B
37.12%2.89B
28.95%2.13B
-15.32%2.53B
-49.04%2.18B
-50.31%2.11B
-60.36%1.65B
-15.39%2.99B
-10.02%4.29B
35.81%4.24B
199.29%4.16B
336.64%3.53B
978.01%4.76B
Total equity
-4.38%20.47B
2.09%21.86B
-7.60%16.56B
-8.71%16.04B
-8.16%15.99B
-9.79%16.73B
-3.36%17.92B
-5.22%17.57B
-3.75%17.41B
0.69%18.54B
-0.18%18.54B
1.14%18.54B
9.60%18.09B
22.17%18.42B
74.25%18.58B
143.91%18.33B
253.40%16.51B
625.65%15.07B
810.35%10.66B
856.32%7.52B
Net operating income
-92.86%12.11M
44.27%-492.23M
162.33%266.58M
215.39%677.81M
-91.48%126.62M
-134.17%-690.03M
-154.88%-427.71M
-177.59%-587.39M
-62.74%1.49B
52.13%-294.67M
1.47%779.36M
-84.13%757.07M
3.72%3.99B
-116.04%-615.59M
529.50%768.06M
268.38%4.77B
4598.37%3.84B
1595.08%3.84B
-184.04%-178.83M
893.84%1.29B
Net investment
-54.88%-115.41M
119.69%3.10B
-519.15%-2.35B
-514.92%-803.35M
74.75%-55.66M
151.49%1.10B
122.69%560.10M
88.64%-130.64M
89.42%-220.42M
-220.22%-2.14B
-1555.27%-2.47B
-1283.15%-1.15B
-2608.80%-2.08B
-345.44%-668.30M
64.37%-149.13M
76.39%-83.14M
-202.88%-76.90M
1266.99%272.29M
-391.06%-418.52M
-1943.76%-352.08M
Net financing
-712.90%-125.09M
297.70%30.87M
-82.76%-12.32M
-37.47%-9.98M
45.02%-11.50M
-68.38%-12.20M
42.96%-6.74M
97.50%-7.26M
85.92%-20.91M
97.26%-7.24M
80.28%-11.82M
55.49%-290.25M
80.63%-148.52M
-447.96%-264.72M
-36.72%-59.93M
-14162.64%-652.16M
-688.43%-766.55M
2150.55%76.08M
-144.15%-43.83M
-100.86%-4.57M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Biontech SE?

According to Biontech SE's FY2025 earnings report, its total revenue reached 3.33B, with a year-on-year change of 2.98B.

What are the current assets of Biontech SE?

According to Biontech SE's FY2025 earnings report, its current assets were 18.75B, with a year-on-year change of -7.96.

What are the total assets of Biontech SE?

According to Biontech SE's FY2025 earnings report, its total assets of Biontech SE were 25.53B, with a year-on-year change of 4.61.

What are the total liabilities of Biontech SE?

According to Biontech SE's FY2025 earnings report, its total liabilities of Biontech SE were 3.21B, with a year-on-year change of -4.99.

What is the total equity of Biontech SE?

According to Biontech SE's FY2025 earnings report, its total equity of Biontech SE was 22.32B, with a year-on-year change of 6.15.

What is the net operating income of Biontech SE?

According to Biontech SE's FY2025 earnings report, its net operating income of Biontech SE was -250.43M, with a year-on-year change of 53.89.

What is the net investment of Biontech SE?

According to Biontech SE's FY2025 earnings report, its net investment of Biontech SE was -2.87B, with a year-on-year change of -27.13.

What is the net financing of Biontech SE?

According to Biontech SE's FY2025 earnings report, its net financing of Biontech SE was -61.42M, with a year-on-year change of -23.53.

What is the Earnings Per Share (EPS) of Biontech SE?

According to Biontech SE's FY2025 earnings report, its Earnings Per Share (EPS) was -5.52, with a year-on-year change of -92.68.

What is the net income of Biontech SE?

According to Biontech SE's FY2025 earnings report, its net income was -1.32B, with a year-on-year change of -83.03.

What is the net margin of Biontech SE?

According to Biontech SE's FY2025 earnings report, its net profit margin was -39.59, with a year-on-year change of -63.70.

What is the gross margin of Biontech SE?

According to Biontech SE's FY2025 earnings report, its gross margin was 84.37, with a year-on-year change of -0.62.

What is the debt-to-asset ratio of Biontech SE?

According to Biontech SE's FY2025 earnings report, its debt-to-asset ratio was 1.13, with a year-on-year change of -85.45.

What is the Return on Equity (ROE) of Biontech SE?

According to Biontech SE's FY2025 earnings report, its Return on Equity (ROE) was -5.88, with a year-on-year change of -75.28.

What is the Return on Assets (ROA) of Biontech SE?

According to Biontech SE's FY2025 earnings report, its Return on Assets (ROA) was -5.10, with a year-on-year change of -74.67.

What is the operating profit of Biontech SE?

According to Biontech SE's FY2025 earnings report, its operating profit was -250.43M, with a year-on-year change of 53.89.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.